By Dr. Charles Kamen, MD — Board-Certified Neurologist, LiveWell21, Las Vegas, NV
Albert Einstein College of Medicine (MD, 2011) | Yale-New Haven Hospital Internship (2011–2012) | Loma Linda University Neurology Residency (2015–2018) | ABPN Board Certified
The question my patients most often bring me isn't "how do I live to 100?" It's something more immediate and more human: "How do I make sure the years I have are actually good ones?"
That's the real promise of longevity medicine — not extending the tail end of a diminished life, but expanding the healthy, functional, cognitively sharp portion of it. Researchers call this "healthspan," and it's a meaningfully different goal than simply lifespan. The field has moved far enough in the last decade that we now have credible, mechanistically grounded tools — not just wellness platitudes — for pursuing it.
I'm a board-certified neurologist practicing at LiveWell21 in Las Vegas. Longevity medicine sits at an unusual intersection for me: it's where neuroscience, endocrinology, cellular biology, and metabolic medicine meet. The brain is both the organ most sensitive to aging — and the one most worth protecting. Everything I do in longevity medicine is viewed through that lens.
This post is an overview of how I think about aging, what longevity medicine actually involves at a clinical level, and how the tools I use — peptides, hormone optimization, and senolytic protocols — fit together as a system.
Longevity medicine — sometimes called precision aging, healthspan medicine, or functional longevity medicine — is the application of emerging scientific knowledge about aging mechanisms to clinical practice. It operates from a fundamental premise: aging is not simply inevitable decline, but a biological process with identifiable mechanisms, many of which are modifiable.
This is meaningfully different from conventional anti-aging medicine, which has historically been dominated by cosmetic concerns and unsubstantiated supplement stacks. And it's different from standard preventive medicine, which tends to focus on disease treatment and risk reduction rather than the optimization of biological function.
Longevity medicine draws on a growing body of research into what scientists call the "Hallmarks of Aging" — a framework first published in Cell in 2013 and updated in 2023 — that identifies the core biological processes underlying the aging phenotype.1 These include:
The interventions I use at LiveWell21 target several of these mechanisms — not in isolation, but as part of a coordinated approach tailored to each patient's biology, biomarkers, and goals.
Peptides are short chains of amino acids that function as biological signaling molecules. The body uses them constantly — for tissue repair, immune modulation, metabolic regulation, hormone secretion, and more. As we age, the production of certain peptides declines, and the signaling pathways they regulate become less efficient.
Peptide therapy at LiveWell21 involves the use of carefully selected peptides — administered via subcutaneous injection or other routes — to support specific biological functions. The ones I use most frequently include:
Peptide therapy is not a replacement for foundational lifestyle habits, and it's not a shortcut. It's a targeted signal — aimed at biological processes that are measurably declining — used alongside the fundamentals.
Hormonal decline is one of the best-characterized aspects of biological aging. Testosterone, estrogen, progesterone, DHEA, growth hormone, and others all follow predictable decline curves with age — and the downstream effects on energy, body composition, cognition, bone density, cardiovascular risk, and quality of life are well-documented.
Hormone optimization at LiveWell21 begins with comprehensive testing — not a single testosterone number, but a full panel including free and total sex hormones, thyroid markers, adrenal function, metabolic markers, and inflammatory status. From there, we build a personalized plan.
Where bioidentical hormone replacement therapy is appropriate, I use it. The evidence base for menopausal hormone therapy has been substantially rehabilitated since the initial WHI concerns; current guidelines from the Menopause Society support its use in appropriate candidates, particularly those within 10 years of menopause onset or under age 60.2 For men with documented hypogonadism, the 2023 TRAVERSE trial provided important cardiovascular safety data supporting testosterone therapy as a tool that can be used carefully in the right population.3
As a neurologist, I bring particular interest to the brain-hormone connection. Estrogen has neuroprotective properties and plays a role in cognitive health; the timing of menopause and hormone therapy may influence dementia risk — an area of active research. Testosterone influences dopamine signaling, mood regulation, and cognitive performance. Thyroid hormones govern myelination and metabolic rate in the brain. Hormonal optimization isn't just about how your body feels — it's about protecting your most important organ.
Senescent cells — damaged cells that have stopped dividing but remain metabolically active, secreting inflammatory signals — accumulate with age and are now understood to drive several hallmarks of aging. Senolytics are compounds that selectively eliminate these cells.
The research foundation here comes substantially from the Mayo Clinic, where Dr. James Kirkland's lab has demonstrated that clearing senescent cells in animal models extends healthspan, improves physical function, and reduces the burden of age-related disease. Early human trials are now reporting promising results in conditions like idiopathic pulmonary fibrosis, diabetic kidney disease, and frailty.4
At LiveWell21, senolytic protocols typically involve a pulsed, intermittent regimen — not daily administration — using agents like dasatinib with quercetin, or fisetin, depending on the patient's clinical picture. I monitor biomarkers of cellular aging and inflammation to track whether the protocol is producing measurable biological effect.
I want to be clear about where the science stands: senolytic therapy for healthy aging is still in the investigational phase from a large-trial evidence standpoint. The mechanistic rationale is strong, the animal data is compelling, and the early human data is promising. We don't yet have long-term randomized trial data in the general aging population. I discuss this openly with patients, and we decide together whether the current evidence supports inclusion of senolytics in their protocol.
The real power of longevity medicine isn't in any single intervention — it's in the integration. Here's how the tools fit together at a biological level:
The goal isn't to layer on every available intervention. It's to identify the highest-leverage biological targets for a specific individual — based on their biomarkers, symptoms, history, and goals — and address those systematically.
I trained as a neurologist because I believe the brain is what makes a life a life. Neurological disease — Alzheimer's, Parkinson's, vascular dementia, peripheral neuropathy — robs people of the capacities that matter most: memory, independence, relationships, identity.
What I've come to believe, working in longevity medicine, is that many of the biological processes that drive neurological aging are the same ones that drive systemic aging. Chronic inflammation. Hormonal decline. Senescent cell accumulation. Metabolic dysfunction. Mitochondrial inefficiency. These are not separate processes happening in separate compartments — they're one process, unfolding throughout the body and the brain simultaneously.
Longevity medicine, done right, is preventive neurology as much as anything else. The choices we make in our 40s, 50s, and 60s about inflammation, metabolic health, hormones, and sleep have downstream effects on brain health that will manifest decades later. I'd rather help people get ahead of that curve than intervene after significant damage has accumulated.
That's not pessimism — it's optimism with a plan.
Longevity medicine at LiveWell21 in Las Vegas is appropriate for adults who:
Longevity medicine is not for people looking for a shortcut. It requires engagement — with your own biology, with the monitoring process, with the lifestyle foundations that make any intervention meaningful. Patients who do well in this model are curious, willing to track and adjust, and realistic about what evidence supports and what it doesn't.
At LiveWell21, the first step is a comprehensive consultation — a thorough review of your history, current symptoms, goals, and a broad initial lab panel. From there, we build a personalized longevity protocol, typically phased to introduce one intervention at a time so we can track what's working.
Las Vegas residents — and those willing to travel for an initial consultation — can book directly through our patient booking system. Telehealth follow-ups are available for existing patients.
Aging is inevitable. Aging badly is not. Let's build a plan.
Book a Longevity Consultation at LiveWell21
Explore our services:
Hormone Optimization | Testosterone Therapy | Senolytic Protocols | Peptide Therapy
This content is for educational purposes and does not constitute medical advice. Consult a qualified physician before beginning any longevity medicine protocol.